Posts

Showing posts from July, 2021

Veterinary Dental Equipment Market worth $500 million by 2026

According to the new market research report " Veterinary Dental Equipment Market by Product (dental equipment, Hand instruments, consumables and Adjuvants), Animal type (Small companion and large animal), End User (Hospitals, Clinics, Academic institute) - Global Forecast to 2026", published by MarketsandMarkets™, the market is projected to reach USD 500 million by 2026 from USD 334 million in 2021, at a CAGR of 8.4% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155083837 The Growth in the global companion animal population, rising incidence of veterinary dental problems, and growth in the number of veterinary practitioners and their income levels in developed economies are the primary drivers for the veterinary dental equipment market. However, the increasing cost of pet care is expected to restrain the growth of this market to a certain extent. This problem will be further exacerbated by the low

Disposable Medical Device Sensors Market worth $9.4 billion by 2026

  According to the new market research report " Disposable Medical Device Sensors Market by Product (Biosensor, Image sensor, Accelerometer), Type (Strip Sensors, Invasive Sensors, Wearable Sensors), Application (Diagnostic Testing, Therapeutics, Patient Monitoring, Imaging) - Global Forecast to 2026", published by MarketsandMarkets™, the Disposable Medical Device Sensors Market is projected to reach USD 9.4 billion by 2026 from USD 6.5 billion in 2021, at a CAGR of 7.7% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1259 The Market growth is largely driven by rising concerns over hospital-acquired infections and contamination, the increasing incidence of target conditions, the growing demand for home-based medical care devices, significant technological advancements in the last few years, and government support for R&D activities for these devices. Biosensors segment accounted for the larger share of

Interventional Cardiology Market worth USD 21.2 billion by 2025

 According to the new market research report Interventional Cardiology Market size is projected to reach USD 21.2 billion by 2025 from USD 13.8 billion in 2020, at a CAGR of 8.9%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=548 North America accounted for the largest share of the interventional cardiology market in 2019. North America accounted for the largest share of the interventional cardiology market in 2019. The large share of this segment can primarily be attributed to the rising incidence of cardiovascular diseases, the growing geriatric population, and the strong presence of industry players in the region. The Growth in the Interventional Cardiology Devices Market is driven mainly by the rapid growth in the geriatric population and the associated increase in the prevalence of coronary artery diseases, approval of new and advanced products, and the growing preference for minimally invasive surgeries. The old/normal balloons segment a

Coagulation Analyzer Market worth USD 5.0 billion by 2025

According to market research report the Coagulation Analyzer Market is projected to reach USD 5.0 billion by 2025 from USD 3.8 billion in 2020, at a CAGR of 5.7% between 2020 and 2025. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197226392 The growth of the global Hemostasis Analyzer Market is largely driven by the increasing prevalence of cardiovascular diseases and blood disorders, technological advancements in coagulation analyzers, and the rising geriatric population. Emerging economies and growing number of reagent rental agreements are expected to offer growth opportunities to market players in the coming years. Siemens Healthineers (Germany), Thermo Fisher Scientific (US), Roche Diagnostics (Switzerland), Alere, Inc. (US), Sysmex Corporation (Japan), Nihon Kohden Corporation (Japan), Diagnostica Stago (France), Helena Laboratories (US), and Horiba Medical (Japan) are some of the key players operating in this Coagulation Analyzer Mark

AI in Genomics Market worth USD 1,671 million by 2025

 According to the new market research report AI in Genomics Market is projected to reach USD 1,671 million by 2025 from USD 202 million in 2020, at a CAGR of 52.7% between 2020 and 2025 Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36649899 The need to control drug development and discovery costs and time, increasing public and private investments in AI in genomics, and the adoption of AI solutions in precision medicine are driving the growth of this market. However, the lack of a skilled AI workforce and ambiguous regulatory guidelines for medical software are expected to restrain the market growth during the forecast period. Based on functionality, the Artificial Intelligence in Genomics Market is segmented into genome sequencing, gene editing, clinical workflows, and predictive genetic testing & preventive medicine. Genome sequencing was the largest functionality segment in this market in 2019 and is estimated to grow at highest CAGR

In Vitro Toxicity Testing Market is expected to reach USD 14.9 billion by 2025

  According to the new market research report In Vitro Toxicity Testing Market is expected to reach USD 14.9 billion by 2025 from an estimated USD 9.1 billion in 2020, at a CAGR of 10.3%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209577065 Due to covid-19 outbreak, there has been a significant increase in Covid-19 testing and drug research. The research in this area is being further undertaken to understand the dynamics of the infection better, which is expected to propel the in vitro toxicology research field further. On the other hand, we are estimating that the major share of diagnostic assays and molecular testing of Covid-19, along with personalized medicine will grow at a stable pace in the next five years. There is a huge increase of manufacturers that have taken key steps to increase patient access to coronavirus diagnostic testing, vaccine and drug development in laboratories, hospitals, and other testing sites across the countr

Gene Editing Market Recent Developments and Future Trends

According to research report the Gene Editing Market is projected to reach USD 6.28 billion by 2022 from USD 3.19 billion in 2017, at a CAGR of 14.5% during the forecast period. Ask For PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231037000 The market growth is largely driven by factors such as the rise in government funding, growth in the number of genomics projects, high prevalence of infectious diseases and cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics. However, the high cost of genomic equipment will restrain the growth of this market. Based on application, the genome editing/genome engineering market is segmented into cell line engineering, genetic engineering, diagnostic applications, drug discovery & development, and other applications. A number of factors, such as the increased funding from governments and private organizations, growing industry focus on

Spatial Genomics Market worth USD 404 million by 2025

  According to the new market research report the global spatial genomics market is projected to reach USD 404 million by 2025 from USD 178 million in 2020, at a CAGR of 17.8% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170900551 The major factors driving the growth of the spatial genomics and transcriptomics market are the increasing adoption of spatial genomics and transcriptomics techniques for drug discovery & development and the increasing R&D investments and public-private funding. Additionally, the introduction of technologically advanced instruments for spatial genomics analysis is also boosting the market growth. However, the high capital investments associated with spatial genomics and transcriptomics are a major factor restraining market growth. Spatial genomics & transcriptomics market is categorized into major four product categories, techniques, product, application and end user. Among

Immunoassay Market worth $39.0 billion by 2026

  According to the new market research report " Immunoassay Market by Product (Reagents & Kits, Analyzers), Technology (ELISA, IFA, Rapid Tests, Radio Immunoassay), Specimen (Blood, Saliva, Urine), Application (Infectious Diseases, Oncology), End User (Hospitals & Clinics) - Global Forecast to 2026", published by MarketsandMarkets™, the global Immunoassay Market is projected to reach USD 39.0 billion by 2026 from USD 28.4 billion in 2021, at a CAGR of 6.6% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=436 The surging incidence of chronic and infectious diseases, technological advancements of immunoassay products, and their massive adoptions are the major factors driving the growth of the market. In 2020, reagents & kits accounted for the largest share of the market and is also expected to grow at the highest CAGR during the forecast period. Based on the product, the immunoassay market is se

Clinical Microbiology Testing Market worth USD 5.3 billion by 2025

 According to the new market research report Clinical Microbiology Testing Market is estimated to be USD 3.9 billion in 2020 and projected to reach USD 5.3 billion by 2025, at a CAGR of 6.5%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219135367 The increasing prevalence of infectious diseases and growing outbreak of epidemics (such as COVID-19), technological advancements, and increased funding and public-private investments are the key factors driving the growth of the orthopedic braces and supports the industry. The clinical microbiology market includes major Tier I and II suppliers like bioMérieux (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), and Roche Diagnostics (Switzerland). Other prominent players include Thermo Fisher Scientific (US), QIAGEN (Netherlands), 3M (US), Bio-Rad Laboratories (US), Bruker Corporation (US), and Hologic (US). These suppliers have their manufacturing faci

IVD Quality Control Market worth USD 1,158 Million by 2025

 According to research report the IVD Quality Control Market is projected to reach $1,158 million by 2025 from $961 million in 2020, at a CAGR of 3.8% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198032582 Some of the factors driving the growth of the In Vitro Diagnostics Quality Control Market are increasing number of accredited clinical laboratories, rising demand for external quality assurance support, and growing adoption of third-party quality controls. The molecualr diagnostics segment is expected to grow at the highest CAGR during the forecast period. Based on applications, the IVD quality control market is segmented into clinical chemistry, immunochemistry, hematology, coagulation & hemostasis, microbiology, molecular diagnostics, and other applications (ESR, urine chemistry, immunology, cardiac assessment, and blood morphology). The molecular diagnostics segment is expected to grow at the high

Cardiac Monitoring Market worth USD 26.8 billion by 2025

 According to the new market research report Cardiac Monitoring Market is projected to reach USD 26.8 billion by 2025 from USD 22.1 billion in 2020, at a CAGR of 4.0% from 2020 to 2025. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=55 The growth of this market is driven by the increasing prevalence of cardiovascular diseases; availability of reimbursement for CM & CRM devices; launch of innovative products by market players; increasing investments, funds, and grants for research on CM & CRM devices; and the growing preference for wearable cardiac devices. The major players operating in this Cardiac Monitoring Market are Medtronic (Ireland), Boston Scientific (US), Abbott Laboratories (US), GE Healthcare (US), BIOTRONIK (Germany), and Koninklijke Philips (Netherlands), Asahi Kasei Corporation (Japan), MicroPort Scientific Corporation (China), Hill-Rom Holdings (US), Nihon Kohden (Japan), SCHILLER AG (Switzerland), BioTelemetry (US), B

ECG Market worth USD 10.3 billion by 2024

According to the new market research report global Diagnostic Electrocardiograph ECG Market is expected to reach USD 10.3 billion by 2024 from USD 7.5 billion in 2019, at a CAGR of 6.4% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173 The Factors such as the rising incidence of lifestyle & cardiovascular diseases and increasing geriatric population are expected to propel the growth of the market. Asia Pacific diagnostic ECG market is expected to grow at the highest CAGR during the forecast period On the basis of region, the diagnostic ECG market is segmented into North America, Europe, Asia Pacific, and RoW. The Asia Pacific is expected to grow at the highest CAGR during the forecast period. Factors such as growth in the geriatric population, growing incidence of chronic diseases, rising healthcare spending, healthcare reforms for infrastructural development, growing demand for advanced technologies, and less

X-Ray Detectors Market worth USD 3.8 billion by 2024

 According to research report the global X-Ray Detectors Market is projected to reach USD 3.8 billion by 2024 from USD 2.8 billion in 2019, at a CAGR of 6.1% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=7004984 Factors such as declining prices and benefits offered by digital detectors, growing public and private investments in Digital Imaging technologies and reimbursement cuts for analog X-rays are driving the growth of the X-ray detectors market. Based on type, the market is segmented into flat-panel detectors (FPDs), computed radiography (CR) detectors, charge-coupled device (CCD) detectors, and line-scan detectors. In 2019, the flat-panel detectors segment is expected to account for the largest share of the X-ray detectors market. The growth in this market is mainly driven by the advantages offered by FPD-based portable digital systems (such as high-quality images, faster scanning, increased patient throughpu

Ambulatory EHR Market Opportunities and Challenges

According to the research report the ambulatory EHR market size is projected to reach USD 6.8 billion by 2025 from USD 5.2 billion in 2020, at a CAGR of 5.7% during the forecast period. Ask For PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235617627 The key factors propelling the growth of the global ambulatory EHR market are government support for the adoption of HCIT, an increase in the COVID-19 patient volume, growing usage of EHR solutions, and the need to curtail healthcare costs. On the other hand, heavy infrastructure investments and the high cost of deployment are limiting the growth of the global ambulatory EHR market to a certain extent. On the basis of application, the global ambulatory EHR market has been segmented into practice management, patient management, e-prescribing, referral management, population health management, decision support, and health analytics. The practice management segment commanded the largest share of the global a

Cancer Immunotherapy Market worth USD 119.39 Bill by 2021

According to research report the Cancer Immunotherapy Market is projected to reach USD 119.39 Billion by 2021 from USD 61.97 Billion in 2016, at a CAGR of 14.0%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197577894 This growth can be attributed to factors such as emergence of biosimilars, increasing adoption of target therapy over traditional therapy, increasing demand for mAbs, high prevalence of cancer. Some of the key players in the cancer immunotherapy market are Amgen Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Bristol-Myers Squibb Company (U.S.), Merck & Co., Inc. (U.S.), Seattle Genetics Inc. (U.S.), Celgene Corporation (U.S.), Eli Lilly and Company (U.S.). Cancer immunotherapy drugs are designed to alter or boost the body’s natural immune response to fight cancer this market is research-driven with a high degree of dependence on the discovery of molecules that can generate an immune response against various indication

Veterinary Reference Laboratory Market Opportunities and Challenges

  According to research report the veterinary reference laboratories market size is projected to reach USD 5.6 billion by 2025 from USD 3.4 billion in 2020, at a CAGR of 10.5%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256972714 Factors such as growth in the companion animal population, rising demand for pet insurance, increasing demand for animal-derived food products, and increasing incidence of transboundary and zoonotic diseases, an increasing number of veterinary practitioners in developed economies are driving the growth of this market during the forecast period. However, rising pet care costs and the increasing demand for POC testing and portable instruments are restraining the growth of this market to some extent. The veterinary reference lab market is segmented based on the type of service, application, animal, and region. Due to lockdown restrictions and social distancing protocols due to COVID-19 across various countries throu

eHealth Market Challenges and Opportunities

According to the new market research report eHealth Market is projected to reach USD 193.8 billion by 2025 from USD 69.5 billion in 2020, at a CAGR of 22.8% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=11513143 The shift toward patient-centric care coupled with the rising digitization of products and services enables remote recording and remote sharing of medical records, mHealth apps and telemedicine services help in monitoring various health parameters at home, eliminating the need for hospital visits Based on eHealth solutions, EHR/EMR Solutions, Medical Apps, Picture Archiving and Communication, Systems & Vendor Neutral Archive, Chronic Care Management Apps, PHR & Patient Portals, Health Information Exchange Solutions, Telehealth Solutions, Pharmacy Information Systems, Laboratory Information Systems, Clinical Decision Support Systems, E-Prescribing Solutions, Radiology Information Systems, Cardiovasc

EMS Products Market Current Trends and Future Opportunities

  According to the new market research report EMS Products Market is expected to reach USD 25.56 Billion by 2022 from USD 19.01 Billion in 2017, at a CAGR of 6.1%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=195094847 The market growth is primarily driven by increasing incidence of trauma injuries; the high demand for emergency care; and growing investments by government bodies on healthcare infrastructure development. Life Support and Emergency Resuscitation Equipment are estimated to account for the largest market share in 2017 By type, the EMS products market is classified into life support and emergency resuscitation equipment, patient monitoring systems, wound care consumables, patient handling equipment, infection control supplies, personal protection equipment, and other EMS products. The life support and emergency resuscitation equipment segment is expected to hold the largest share of the global EMS products market in 2017. The ris

MIS Instruments Market Development And Business Intelligence

Global market size- According to research report the MIS instruments market is expected to reach $ 32.7 billion by 2025, at a CAGR of 8.5% during the forecast period.  Market growth influenced due to following factors- Advantages of minimally invasive surgeries over traditional open surgeries. Increasing number of minimally invasive surgical procedures performed across the globe. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682 Leading Players- The major companies in the global MIS instruments market include Medtronic plc (Ireland), Johnson & Johnson (US), Stryker Corporation (US), B. Braun Melsungen AG (Germany), Smith & Nephew plc (US), Boston Scientific Corporation (US), and CONMED Corporation (US). Top Market Segments- Based on type of surgery, the global MIS instruments market is divided into cardiothoracic surgery, gastrointestinal surgery, orthopedic surgery, gynecological surgery, cosmetic & bariatric surgery, urological s

Defibrillators Market worth $11.7 billion by 2025

According to the new market research report Defibrillators Market is projected to reach USD 11.7 billion by 2025 from USD 9.6 billion in 2019, growing at a CAGR of 3.4% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=549 The growth in this market is driven by the rising prevalence of target diseases, growing focus on providing public-access defibrillators, and training and awareness programs on defibrillators. In addition, emerging markets and the development of S-ICDs and MRI-compatible ICDs and CRT-Ds are expected to offer growth opportunities for players in the defibrillators market. However, issues related to the use of implantable and automated external defibrillators, frequent product recalls, and a lack of awareness about sudden cardiac arrest in developing nations are expected to hinder the growth of the defibrillators market during the forecast period. The ICDs segment accounted for the largest share of th